Nexstim Plc (HEL:NXTMH)
Finland
· Delayed Price · Currency is EUR 7.88
+0.06 (0.77%)
Apr 24, 2025, 6:12 PM EET
Nexstim Revenue
In the year 2024, Nexstim had annual revenue of 10.21M EUR with 18.97% growth. Nexstim had revenue of 6.26M in the half year ending December 31, 2024, with 91.06% growth.
Revenue
10.21M
Revenue Growth
+18.97%
P/S Ratio
5.50
Revenue / Employee
255.33K
Employees
40
Market Cap
56.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.21M | 1.63M | 18.97% |
| Dec 31, 2023 | 8.58M | -2.18M | -20.23% |
| Dec 31, 2022 | 10.76M | 3.21M | 42.44% |
| Dec 31, 2021 | 7.56M | 3.40M | 81.87% |
| Dec 31, 2020 | 4.15M | 767.53K | 22.66% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.54B |
| Terveystalo Oyj | 1.34B |
| Revenio Group Oyj | 103.82M |
| Pihlajalinna Oyj | 704.92M |
| Nightingale Health Oyj | 4.95M |
| Aiforia Technologies Oyj | 2.85M |
| Nanoform Finland Oyj | 3.66M |
| Optomed Oyj | 15.05M |